Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 3.205
-0.210 (-6.15%)
Oct 13, 2026, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 1.05 billion as of October 13, 2026. It is the 24,325th most valuable company in the world and the 162nd biggest in Norway. Its market cap has increased by 51.90% in one year.
Market Cap
1.05B
Enterprise Value
620.57M
Revenue
4.60M
Global Rank
Country Rank
#162 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 1.05B, a decrease of -81.05%. That is a compound annual growth rate of -21.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 1.05B | 32.88% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.06B |
| Thor Medical ASA | 1.88B |
| ArcticZymes Technologies ASA | 1.00B |
| Lytix Biopharma ASA | 630.58M |
| Zelluna ASA | 586.76M |
| Oncoinvent ASA | 428.99M |
| SoftOx Solutions AS | 310.13M |
| Arctic Bioscience AS | 71.16M |